Trial · NCT07877116
Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation
NCT07877116, Phase 4, Not yet recruiting, Hüseyin Ulaş Pinar
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation. Trials, record NCT07877116. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07877116
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation
- NCT number
- NCT07877116
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 124 participants, estimated
- Lead sponsor
- Hüseyin Ulaş Pinar
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Sevoflurane, propofol
- First posted
- 2026-10-16
- Last updated
- 2026-10-16
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Atrial Tachyarrhythmia Recurrence at 6 Months | From the date of the ablation procedure through 6 months after the procedure | The proportion of participants with atrial tachyarrhythmia recurrence at 6 months after radiofrequency catheter ablation will be assessed during routine cardiology follow-up and obtained from medical records. |
| Secondary | Acute Procedural Success | At the end of the ablation procedure | The proportion of participants in whom the radiofrequency catheter ablation procedure is successfully completed as intended at the end of the procedure will be assessed. |
| Secondary | Mapping Time | During the ablation procedure | Mapping time during the radiofrequency catheter ablation procedure will be recorded from the intraoperative procedure records. |
| Secondary | Ablation Time | During the ablation procedure | Ablation time during the radiofrequency catheter ablation procedure will be recorded from the intraoperative procedure records. |
| Secondary | Total Procedure Time | During the ablation procedure | Total procedure time for the radiofrequency catheter ablation procedure will be recorded from the intraoperative procedure records. |
| Secondary | Hemodynamic Instability | During the ablation procedure | Hemodynamic instability during the procedure will be assessed from intraoperative anesthesia records. Mean arterial pressure will be recorded during the procedure. |
| Secondary | Change in Quality of Recovery-15 (QoR-15) Score at 24 Hours | Preoperatively and 24 hours after the procedure | Quality of recovery will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire preoperatively and at 24 hours after the procedure. Each of the 15 items is scored from 0 to 10, with higher scores indicating better recovery. |
| Secondary | Procedural Complications | 1. During the ablation procedure | The proportion of participants experiencing procedural complications will be assessed based on intraoperative procedure and anesthesia records. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07877116
GET https://conductscience.org/api/trials/v1/NCT07877116/registered